Metotrexato Aurobindo

Methotrexate, the active ingredient in Metotrexato Aurobindo, is an antimetabolite and immunosuppressant presented as an oral tablet for oral use. It is used to manage autoimmune diseases such as rheumatoid arthritis and psoriasis, as well as to treat several malignancies including acute lymphoblastic leukemia and non‑Hodgkin lymphoma in adult patients.

GNH USA supplies Metotrexato Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards, is available for global distribution, and ensures quality and reliability.

Methotrexate acts on rapidly dividing cells and modulates immune pathways, making it useful in several inflammatory and oncologic conditions.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: diminishes skin lesions and plaque formation. - Acute lymphoblastic leukemia: interferes with leukemic cell proliferation. - Non‑Hodgkin lymphoma: impedes malignant lymphoid growth. - Gestational trophoblastic disease: promotes resolution of trophoblastic tissue. - Osteosarcoma: limits tumor cell replication.

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting. - Stomatitis or mouth ulcers. - Fatigue or malaise. - Alopecia (hair loss). - Elevated liver enzymes. - Mild skin rash.

Serious or Rare Side Effects: - Bone marrow suppression leading to pancytopenia. - Severe hepatotoxicity or fibrosis. - Pulmonary toxicity, including interstitial pneumonitis. - Renal failure due to crystal nephropathy. - Life‑threatening infections.

Before initiating therapy, several precautions should be observed to minimize risk.

- Liver monitoring: check hepatic enzymes regularly. - Blood counts: perform complete blood count before and during treatment. - Renal function: assess creatinine clearance and adjust dose if impaired. - Pregnancy: contraindicated in pregnancy; ensure effective contraception. - Drug interactions: review concomitant medications for potential interactions. - Store at room temperature: keep in original container, protect from moisture and light.

Methotrexate interacts with several medicines, requiring careful management.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Penicillins (e.g., ampicillin): can raise serum methotrexate levels. - Sulfonamide antibiotics: may potentiate adverse effects.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may affect renal clearance. - Azathioprine or leflunomide: additive immunosuppression. - Live vaccines: risk of infection due to immunosuppression.